TP53 and lung carcinoma: A maximal effect was achieved by the combination of olaparib with IR on H4K16 acetylation fluorescence in H1299 (TP53−/−) (Fig. 2) and A549 (Additional file 5: Figure S5) lung cancer cell lines deprived (0.5%) of serum.